Free Trial

NeoGenomics (NEO) Competitors

$13.54
+0.54 (+4.15%)
(As of 10/10/2024 ET)

NEO vs. ETSY, MPLN, QXO, LYFT, TNET, NVEI, MARA, CLVT, ATHM, and ALIT

Should you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include Etsy (ETSY), MultiPlan (MPLN), QXO (QXO), Lyft (LYFT), TriNet Group (TNET), Nuvei (NVEI), Marathon Digital (MARA), Clarivate (CLVT), Autohome (ATHM), and Alight (ALIT). These companies are all part of the "business services" industry.

NeoGenomics vs.

NeoGenomics (NASDAQ:NEO) and Etsy (NASDAQ:ETSY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership, earnings and community ranking.

NeoGenomics presently has a consensus target price of $19.89, suggesting a potential upside of 46.89%. Etsy has a consensus target price of $71.14, suggesting a potential upside of 43.28%. Given NeoGenomics' stronger consensus rating and higher probable upside, equities analysts clearly believe NeoGenomics is more favorable than Etsy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeoGenomics
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90
Etsy
3 Sell rating(s)
12 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.26

In the previous week, Etsy had 12 more articles in the media than NeoGenomics. MarketBeat recorded 18 mentions for Etsy and 6 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 0.91 beat Etsy's score of 0.01 indicating that NeoGenomics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeoGenomics
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Etsy
4 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral

Etsy has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Etsy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeoGenomics$591.64M2.93-$87.97M-$0.62-21.84
Etsy$2.75B2.07$307.57M$2.1523.09

Etsy has a net margin of 10.36% compared to NeoGenomics' net margin of -12.50%. NeoGenomics' return on equity of -2.72% beat Etsy's return on equity.

Company Net Margins Return on Equity Return on Assets
NeoGenomics-12.50% -2.72% -1.53%
Etsy 10.36%-51.94%12.29%

NeoGenomics has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Etsy has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500.

98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 99.5% of Etsy shares are owned by institutional investors. 1.3% of NeoGenomics shares are owned by company insiders. Comparatively, 2.6% of Etsy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Etsy received 342 more outperform votes than NeoGenomics when rated by MarketBeat users. However, 70.86% of users gave NeoGenomics an outperform vote while only 59.37% of users gave Etsy an outperform vote.

CompanyUnderperformOutperform
NeoGenomicsOutperform Votes
501
70.86%
Underperform Votes
206
29.14%
EtsyOutperform Votes
843
59.37%
Underperform Votes
577
40.63%

Summary

Etsy beats NeoGenomics on 12 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEO vs. The Competition

MetricNeoGenomicsTesting laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$1.67B$2.98B$5.41B$8.54B
Dividend YieldN/A1.48%4.44%4.15%
P/E Ratio-21.84N/A92.6512.72
Price / Sales2.932.111,290.4789.27
Price / Cash46.0530.5338.2933.51
Price / Book1.832.734.584.46
Net Income-$87.97M$106.45M$114.32M$227.11M
7 Day Performance-2.87%-3.83%-0.87%0.67%
1 Month Performance-16.98%-21.95%14.26%11.79%
1 Year Performance8.32%-21.33%24.02%19.04%

NeoGenomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEO
NeoGenomics
2.8127 of 5 stars
$13.54
+4.2%
$19.89
+46.9%
+6.3%$1.67B$591.64M-21.842,100
ETSY
Etsy
4.5668 of 5 stars
$51.19
-3.0%
$70.22
+37.2%
-22.1%$5.99B$2.77B23.372,420Short Interest ↑
MPLN
MultiPlan
0.8657 of 5 stars
$9.13
+1.4%
$5.50
-39.8%
N/A$5.89B$954.92M-9.322,800Gap Down
QXO
QXO
0.9974 of 5 stars
$13.67
-2.2%
N/AN/A$5.60B$57.11M-7.77195Short Interest ↑
LYFT
Lyft
4.081 of 5 stars
$12.51
-0.5%
$15.65
+25.1%
+11.0%$5.05B$5.10B-26.622,945Gap Up
TNET
TriNet Group
3.8998 of 5 stars
$96.66
-1.6%
$118.40
+22.5%
-19.2%$4.80B$4.92B15.853,600Positive News
NVEI
Nuvei
2.8957 of 5 stars
$33.38
+0.1%
$32.21
-3.5%
+109.1%$4.67B$1.31B-834.502,202Positive News
MARA
Marathon Digital
3.4269 of 5 stars
$15.99
-2.0%
$19.61
+22.7%
+80.0%$4.52B$564.95M7.449Analyst Forecast
CLVT
Clarivate
2.288 of 5 stars
$6.53
-2.0%
$7.71
+18.1%
+0.0%$4.36B$2.60B-3.9312,000Positive News
ATHM
Autohome
2.569 of 5 stars
$33.94
-0.3%
$28.00
-17.5%
+8.9%$4.26B$7.30B16.095,511Short Interest ↓
Positive News
ALIT
Alight
2.7599 of 5 stars
$7.20
-1.5%
$10.75
+49.3%
+4.4%$4.04B$3.36B-11.6118,000Short Interest ↑

Related Companies and Tools


This page (NASDAQ:NEO) was last updated on 10/11/2024 by MarketBeat.com Staff
From Our Partners